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Abstract
Background: The Korean healthcare system is composed of costly and inefficient structures that fail to adequately
divide the functions and roles of medical care organizations. To resolve this matter, the government reformed the
cost-sharing policy in November of 2011 for the management of outpatients visiting general or tertiary hospitals
with comparatively mild diseases. The purpose of the present study was to examine the impact of increasing the
coinsurance rate of prescription drug costs for 52 mild diseases at general or tertiary hospitals on outpatient
healthcare service utilization.
Methods: The present study used health insurance claim data collected from 2010 to 2013. The study population
consisted of 505,691 outpatients and was defined as those aged 20–64 years who had visited medical care
organizations for the treatment of 52 diseases both before and after the program began. To examine the effect of the
cost-sharing policy on outpatient healthcare service utilization (percentage of general or tertiary hospital utilization,
number of outpatient visits, and outpatient medical costs), a segmented regression analysis was performed.
Results: After the policy to increase the coinsurance rate on prescription drug costs was implemented, the number of
outpatient visits at general or tertiary hospitals decreased (β = −0.0114, p < 0.0001); however, the number increased at
hospitals and clinics (β = 0.0580, p < 0.0001). Eventually, the number of outpatient visits to hospitals and clinics began
to decrease after policy initiation (β = −0.0018, p < 0.0001). Outpatient medical costs decreased for both medical care
organizations (general or tertiary hospitals: β = −2913.4, P < 0.0001; hospitals or clinics: β = −591.35, p < 0.0001), and this
decreasing trend continued with time.
Conclusions: It is not clear that decreased utilization of general or tertiary hospitals has transferred to that of clinics or
hospitals due to the increased cost-sharing policy of prescription drug costs. This result indicates the cost-sharing
policy, intended to change patient behaviors for healthcare service utilization, has had limited effects on rebuilding the
healthcare system and the function of medical care organizations.
Keywords: Increased coinsurance rate, Prescription drug cost policy, Healthcare utilization, Outpatient visit, Medical
costs
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Background
Since South Korea established a national health insur-
ance program in 1989, health expenditures and accessi-
bility to healthcare and medical needs have rapidly
increased [1]. In South Korea, total health expenditures
accounted for 7.6% of gross domestic production in
2012 [2]. This total health expenditure is lower than the
Organization for Economic Co-operation and Develop-
ment (OECD) average of 9.3%. However, the growth rate
in health expenditure per person from 2001 to 2011 is
higher than that of most OECD countries (South Korea:
9.3%; OECD average: 4.0%). Thus, achieving control over
the constantly increasing health expenditure has become
a key healthcare reform concern in South Korea [3].
There have been various discussions surrounding the
financial stability of health insurance in South Korea.
One of the proposed strategies is to build a sustainable
healthcare system. To improve healthcare systems, sim-
ultaneous pursuit of three aims—improving the experi-
ence of care, improving the health of populations, and
reducing per capita costs of health care—is required.
The role of the South Korean government, as an integra-
tor that accepts responsibility for these three aims,
includes the redesign of primary care, population health
management, and financial management [4]. In particu-
lar, the South Korean government attempted to improve
primary health care and manage finances efficiently by
assigning an appropriate role for medical care organiza-
tions according to size and function [5]. In South Korea,
medical care is divided between clinical and hospital or-
ganizations by function, and hospitals are further divided
into specialist and general hospitals according to struc-
tural characteristics. Medical law defines clinics (less
than 30 beds) as centers treating outpatients and hospi-
tals (more than 30 beds) as treating inpatients. General
hospitals have more than 100 beds and at least 7 medical
departments, including essential medical departments
designated by medical law. Additionally, the Minister of
Health and Welfare is able to specify tertiary hospitals as
more specialist hospitals treating severe diseases com-
pared to general hospitals with several requirements
such as manpower, facilities, and equipment.
However, despite the use of this classification, individ-
uals are able to choose any medical care organizations,
from clinics in their community to hospitals [6]. Thus,
the South Korean healthcare system contains inefficient
structures that fail to adequately divide the functions
and roles of medical care organizations. Accordingly,
their functions overlap and all medical care organiza-
tions compete with each other, regardless of hospital
type [7]. In addition, patients are focused on general
hospitals in metropolitan areas despite having mild
diseases and have to pay more for hospital services com-
pared to clinic services. When evaluating diagnostic
codes of outpatients according to hospital type, hyper-
tension, diabetes mellitus, and acute upper respiratory
tract infections, which are treatable in the primary
healthcare setting, are the most frequent diseases treated
in all hospital types. In addition, 44 tertiary hospitals
(0.07% of medical care organizations) account for 23% of
health insurance expenditure and this percentage is
increasing [8]. Thus, in October 2011, the government
reformed the policy for the management of outpatients
visiting general hospitals for the care of comparatively
mild diseases. This policy resulted in an increase in the
existing 30% of coinsurance rate on prescription drug
costs for 52 types of diseases to 50% in tertiary hospitals
and 40% in general hospitals [5, 9].
In general, cost sharing, including coinsurance, copay-
ment, and deductible, refers to any financing arrange-
ment where the cost of the services used is supported in
part by the user. The main objective is to prevent un-
necessary utilization of health services and to stabilize
insurance finances [10]. A further objective is to shift
health care expenditures from public to private
resources and secure additional finances to sustain the
functioning of health services [11]. There have been
many previous studies on cost sharing. The findings of
the RAND Health Insurance Experiment and other stud-
ies of non-elderly insured populations reported that cost
sharing reduced total health care spending and
utilization without harming the health of individuals [12,
13]. However, some studies have reported higher cost
sharing to be associated with adverse outcomes, particu-
larly among vulnerable populations such as elderly and
poor patients [14–16]. In studies that were not limited
to patients with certain chronic illnesses, increased cost
sharing was not found to be associated with increased
number of outpatient visits, emergency department
visits, or hospitalizations [17].
Previous research on cost sharing performed by South
Korea found that low-income patients were more sensi-
tive to cost sharing than high-income patients, and users
of general hospitals were less sensitive to cost sharing
than the users of clinics [18]. Furthermore, another
study suggested that cost sharing among the elderly had
little effect on controlling health care utilization [10].
However, some studies have demonstrated that cost
sharing decreases medical costs and visit days per
outpatient [19, 20]. The results of studies regarding the
effect of increasing the coinsurance rate of prescription
drug costs—our policy of interest—were inconsistent [9,
21, 22]. In addition, few studies have considered individ-
ual characteristics, such as sex, age, and income, even
where individual characteristics are important factors for
healthcare utilization, particularly in South Korea due to
free choice of medical care organizations and a payment
system based on fee-for-service. Therefore, the purpose
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of the present study was to examine the impact of chan-
ging the coinsurance rate of prescription drug costs for
52 mild diseases on outpatient healthcare service
utilization using nationally representative data.
Methods
Study population
The present study used National Sample Cohort data,
including all medical claims, from 2010 to 2013 released
by the National Health Insurance Service (NHIS), which
consists of details of patient healthcare utilization. The
data included approximately 100 million people sampled
by sex, age, employment status (employed or self-
employed), income, and individual total medical costs.
Our study population was defined as outpatients aged
20–64 years who had visited medical care organizations
more than once, both before and after the policy change.
for the treatment of 52 diseases, including acute bron-
chitis, gastritis, duodenitis, and hypertension. These 52
diseases are classified according to the International
Classification of Diseases groupings (ICD-10) and details
regarding each type and its description are presented in
the Additional file 1. Additionally, the present study in-
cluded only National Health Insurance (NHI) beneficiar-
ies who were enrolled in health insurance provided by
public sector. Health insurance in South Korea is classi-
fied into either NHI or Medical Aid. Individuals whose
single-family household income is less than $600 per
month qualify for Medical Aid while others should join
NHI. Since NHI and Medical Aid have slightly differing
copayment systems, we included NHI beneficiaries only.
The present study was approved by the Institutional Re-
view Board, Yonsei University Graduate School of Public
Health (2014-239). The requirement for informed con-
sent from patients was waived as patient information
was anonymized prior to the study analysis.
Measures
We used the proportion of general or tertiary hospital
utilization, number of outpatient visits, and medical
costs as dependent variables to reflect the shift of outpa-
tients into hospitals or clinics from general or tertiary
hospitals. All dependent variables were calculated in
units of person–month. General or tertiary hospital
utilization was defined as the proportion of general or
tertiary hospital utilization among total healthcare
utilization. The proportion of general or tertiary hospital
utilization per month was calculated as (the number of
outpatient visits into general or tertiary hospitals per
person–month/the number of outpatient visits into total
healthcare utilization per person–month) × 100. The
numbers of outpatient visits and medical costs per per-
son–month were analyzed by categorizing costs into
general or tertiary hospital and hospital or clinic.
Medical costs indicated the total costs of visiting physi-
cians and prescription drugs. The monetary unit of med-
ical costs was KRW, with 1000 KRW corresponding to
approximately 1 US$.
For the analysis of the relationship between the intro-
duction of the policy and healthcare utilization, we
adjusted for individual characteristics. Individual charac-
teristics included age, sex, income, residence region,
Charlson Comorbidity Index (CCI), and all cause admis-
sion during the previous year. Demographic factors,
including age, sex, income, and residence region, are
known to be associated with health care utilization [23–
25]. Further, health-related factors such as CCI and re-
cently history of admission may affect the pattern of
health care utilization [26–28]. Age in years was classi-
fied into five groups as follows; 20–29, 30–39, 40–49,
50–59, and 60–64. Regions were categorized into urban
and rural. Income level was estimated using the average
monthly health insurance premium. Individuals with
NHI provided by their employer paid a monthly insur-
ance premium according to annual salary, and those
who were self-employed paid a premium according to
their property value. Low-income was defined as the
bottom 20 percentiles of health insurance premiums,
middle-income was defined as the 20–80 percentiles of
the premiums, and high-income was defined as the top
20 percentiles of premiums. The CCI was used to ac-
count for the effects of comorbid disorders or diseases.
CCI was calculated monthly according to Quan’s
methods [29]. Nineteen diseases were classified into
scores of 1, 2, 3, and 6 [30]. The CCI was calculated
from the sum of all scores and given extra scores in ac-
cordance with age. In the present study, CCI was
grouped as scores of 0, 1, 2, and 3 or over.
Statistical analysis
We examined the distribution of individual characteris-
tics by analyzing their frequencies. Student’s t-test was
performed for dependent variables, proportion of general
or tertiary hospital utilization, number of outpatient
visits, and medical costs both before and after the intro-
duction of the program. Segmented regression analysis
of interrupted time series analysis was used to examine
policy effects [31]. Our segmented regression analysis
equation was:
Y it ¼ β0 þ β1  timet þ β2  2011 policyþ β3  time after 2011 policy þ
β4  seasont þ Xit þ eit
Y dependent variables
i each variables
t time period
time a continuous variable beginning in January 2010
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2011 policy changing coinsurance rate on prescription
drug cost in November 2011, a binary variable (0 before;
1 after)
time after 2011 policy a continuous variable beginning in
November 2011
season seasonality (spring, summer, fall, winter)
X independent variables
e error term
In the present study analysis, the 2011 policy began in
November 2011, as there was a 1-month-lagged effect
after implementation of the policy. For the segmented
regression analysis, the Generalized Estimation Equation
(GEE) was used. PROC GENMOD was performed for
the GEE with link identity, normal distribution, and type
= AR (1). Repeated measures were considered and the
unit of analysis was person-month. Subgroup analyses
by income and sex were also performed. All statistical
analyses were performed using SAS statistical software
version 9.2. All calculated p-values were two-sided and
considered statistically significant at p < 0.05.
Results
Table 1 shows the general characteristics of the study
population. A total of 505,691 outpatients were included
in the analysis. The highest proportion was in the 50–59
years old group at 131,556 (26.0%). There were 230,371
(45.6%) men and 275,320 (54.4%) women. More than
half (59.7%) were middle-income earners, lived in an
urban area (71.2%), and had 0 points on the CCI
(64.4%). The majority of the study population had no
disability (96.4%). A total of 48,922 (9.7%) outpatients
were admitted during the previous year. Based on the
number of outpatients, the most common disease was
acute bronchitis, unspecified (ICD-10: J20.9, 335,686
outpatients, 66.4%). When viewed in terms of the total
numbers of visits, patients with essential hypertension
(ICD-10: I10) had the most visits to medical care organi-
zations (1,638,083 cases, 13.6%).
The trends of each dependent variable before and after
the policy are shown in Table 2. The proportion of
general or tertiary hospital utilization was 5.9% before
the 2011 policy and 5.4% after the 2011 policy. The
number of outpatient visits decreased in terms of gen-
eral or tertiary hospital utilization per month but in-
creased in hospital or clinic utilization after the 2011
policy (general or tertiary hospital utilization: 0.099 -
>0.092, p < 0.0001; hospital or clinic utilization: 1.576 -
>1.617, p < 0.0001). Outpatient medical costs also
decreased for general or tertiary hospital utilization per
month but increased in hospital or clinic utilization after
the 2011 policy (general or tertiary hospital utilization:
9273.8 - >6316.4, p < 0.0001; hospital or clinic utilization:
44,935.1 - >46,206.1, p < 0.0001). The trends of each
dependent variable per month are shown in Fig. 1.
Table 3 shows the results of the segmented regression
analysis. The 2011 policy decreased the percentage of
general or tertiary hospital utilization (β = −1.6184, p <
0.0001). After the 2011 policy, the number of outpatient
visits decreased for general or tertiary hospitals (β =
−0.0114, p < 0.0001) and increased for hospitals or
clinics (β = 0.0580, p < 0.0001). However, the number of
outpatient visits in hospitals or clinics exhibited a
Table 1 General characteristics of the study population
Number Percent
Age
20–29 49,609 9.8
30–39 112,854 22.3
40–49 131,077 25.9
50–59 131,556 26.0
60–64 80,595 15.9
Sex
Men 230,371 45.6
Women 275,320 54.4
Income
Low (0–20%) 70,648 14.0
Middle (20.1–80%) 302,061 59.7
High (80.1–100%) 132,982 26.3
Region
Urban 359,964 71.2
Rural 145,727 28.8
Charlson comorbidity index
0 325,786 64.4
1 126,791 25.1
2 41,673 8.2
3+ 11,441 2.3
Disability
Normal 487,371 96.4
Mild disability 15,519 3.1
Severe disability 2,801 0.6
All cause admission at previous year
Non-admission 456,769 90.3
Admission 48,922 9.7
Most frequent disease (ICD-10 code)
Acute bronchitis, unspecified (J20.9) 335,686 66.4
Acute tonsillitis (J03.0 ~ J03.9) 201,650 39.9
Gastritis and duodenitis (K29.0 ~ K29.9) 192,444 38.1
Acute upper respiratory infections of
multiple and unspecified sites (J06.0 ~ J06.9)
173,381 34.3
Allergic contact dermatitis due to other
agents or unspecified cause (L23.8, L23.9)
140,817 27.8
Total 505,691 100.0
Lee et al. BMC Health Services Research  (2017) 17:152 Page 4 of 10
Table 2 The trends of each dependent variable before and after the 2011 policy. Unit: Mean ± SD
Before intervention After intervention p-value
2010.1–2011.9 2011.10–2013.12
Percentage of general and tertiary
hospital utilization
5.921 ± 0.390 5.410 ± 0.380 <0.0001
General and tertiary hospital utilization
Number of outpatient visits 0.099 ± 0.005 0.092 ± 0.006 <0.0001
Outpatient medical costs 9273.8 ± 542.8 6316.4 ± 366.5 <0.0001
Hospital and clinic utilization
Number of outpatient visits 1.576 ± 0.042 1.617 ± 0.041 <0.0001
Outpatient medical costs 44935.1 ± 1242.6 46206.1 ± 976.2 <0.0001
Fig. 1 The trends of each dependent variable for month
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downward trend after the policy. Outpatient medical
costs decreased in both medical care organizations (gen-
eral or tertiary hospitals: β = −2913.4, p < 0.0001; and
hospital or clinic utilization: β = −591.35, p <0.0001).
This trend continued to decrease over time. The per-
centage of general or tertiary hospital utilization by out-
patients with acute bronchitis recovered (β = 0.0167, p =
0.0010), while that by outpatients with essential hyper-
tension decreased (β = −0.0154, p = 0.0029) over time
after the 2011 policy began.
After the policy began, the increasing coinsurance rate,
number of outpatient visits, and outpatient medical costs
in both medical care organizations demonstrated the
same trend in the total population regardless of income
and sex (Table 4). General or tertiary hospital utilization,
including both the number of outpatient visits and out-
patient medical costs, decreased; however, hospital or
clinic utilization did not increase to the same extent as
the decrease in general or tertiary hospital utilization.
Rather, outpatient medical costs decreased. Unlike the
results of the subgroup analysis by income, we identified
that the absolute values of the coefficient for time after
the 2011 policy were higher in women than in men,
indicating women were more likely to be sensitive to the
2011 policy.
Discussion
Medical costs per visit for the same diagnostic code are
higher in larger hospitals and are 3–4 times higher in
tertiary hospitals than in clinics [8]. Thus, if outpatients
are concentrated in tertiary hospitals, health insurance
finances become an economic burden. In addition, since
patients are less likely to visit clinics and small hospitals,
the quality of care in clinics and small hospitals is
reduced, which may lead to patient distrust of clinics
and small hospitals. Patients will be then much less
likely to visit clinics and small hospitals. Once this
vicious cycle is repeated, financial difficulties, both in
health insurance and in clinics or small hospitals, will
further increase [32]. Tertiary hospitals may not be able
to adequately perform their primary function of treating
Table 3 The results of the segmented regression analysis
Time 2011 policy Time after 2011 policy
Estimate* p-value Estimate* p-value Estimate* p-value
Total
Percentage of general or tertiary hospital utilization −0.0044 0.0658 −1.6184 <0.0001 0.0036 0.1786
General and tertiary hospital utilization
Number of outpatient visits 0.0001 0.0034 −0.0114 <0.0001 0.0001 0.3159
Outpatient medical costs 1.3140 0.7452 −2913.4 <0.0001 −23.684 <0.0001
Hospitals and clinic utilization
Number of outpatient visits 0.0001 0.9998 0.0580 <0.0001 −0.0018 <0.0001
Outpatient medical costs 106.41 <0.0001 −591.35 <0.0001 −97.722 <0.0001
Acute bronchitis, unspecified (J20.9)
Percentage of general and tertiary hospital utilization −0.0086 0.0500 −0.6044 <0.0001 0.0167 0.0010
General and tertiary hospital utilization
Number of outpatient visits 0.0001 0.5675 −0.0060 <0.0001 0.0001 0.0983
Outpatient medical costs 6.5779 0.3676 −1144.6 <0.0001 −9.5789 0.2411
Hospital and clinic utilization
Number of outpatient visits 0.0023 <0.0001 0.0110 0.0481 −0.0041 <0.0001
Outpatient medical costs 127.14 <0.0001 −1057.7 <0.0001 −123.28 <0.0001
Essential hypertension (I10.0, I10.9)
Percentage of general and tertiary hospital utilization −0.0164 0.0001 −1.0330 <0.0001 −0.0154 0.0029
General and tertiary hospital utilization
Number of outpatient visits −0.0001 0.1233 −0.0095 <0.0001 −0.0003 <0.0001
Outpatient medical costs −14.902 0.0543 −2381.0 <0.0001 −51.712 <0.0001
Hospital and clinic utilization
Number of outpatient visits 0.0002 0.3478 0.0363 <0.0001 −0.0014 <0.0001
Outpatient medical costs 182.60 <0.0001 −877.34 <0.0001 −202.80 <0.0001
*Adjusted for age, sex, income, region, CCI, disability, and all cause admission during the previous year
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Table 4 The results of the segmented regression analysis by income
Time 2011 policy Time after 2011 policy
Estimate p-value Estimate p-value Estimate p-value
Low-income*
Percentage of general or tertiary hospital utilization 0.0045 0.4908 −1.1350 <0.0001 −0.0066 0.4063
General or tertiary hospital utilization
Number of outpatient visits 0.0002 0.0156 −0.0067 <0.0001 −0.0001 0.5488
Outpatient medical costs 17.348 0.1097 −2146.8 <0.0001 −38.488 0.0026
Hospital or clinic utilization
Number of outpatient visits 0.0001 0.3191 0.054 <0.0001 −0.0024 <0.0001
Outpatient medical costs 113.3 <0.0001 −516.58 0.0111 −116.55 <0.0001
Middle-income*
Percentage of general or tertiary hospital utilization 0.0008 0.8077 −1.2203 <0.0001 −0.0014 0.7231
General or tertiary hospital utilization
Number of outpatient visits 0.0002 <0.0001 −0.0079 <0.0001 0.0001 0.6918
Outpatient medical costs 12.213 0.0173 −2349.3 <0.0001 −32.848 <0.0001
Hospital or clinic utilization
Number of outpatient visits 0.0002 0.3565 0.0490 <0.0001 −0.0018 <0.0001
Outpatient medical costs 110.11 <0.0001 −980.52 <0.0001 −93.052 <0.0001
High-income*
Percentage of general or tertiary hospital utilization −0.0163 0.0017 −1.4079 <0.0001 0.0059 0.3481
General or tertiary hospital utilization
Number of outpatient visits 0.0001 0.6515 −0.0070 <0.0001 0.0001 0.8488
Outpatient medical costs 1.4560 0.8684 −2873.7 <0.0001 −40.050 0.0001
Hospital or clinic utilization
Number of outpatient visits −0.0002 0.5677 0.0576 <0.0001 −0.0013 0.0003
Outpatient medical costs 103.51 <0.0001 −480.34 0.0003 −106.28 <0.0001
Men+
Percentage of general or tertiary hospital utilization −0.0041 0.3630 −1.1856 <0.0001 0.0135 0.0182
General or tertiary hospital utilization
Number of outpatient visits 0.0004 <0.0001 −0.0056 <0.0001 −0.0002 0.0824
Outpatient medical costs 331.91 <0.0001 −2029.9 <0.0001 −441.73 <0.0001
Hospital or clinic utilization
Number of outpatient visits 0.0044 <0.0001 0.0241 <0.0001 −0.0036 <0.0001
Outpatient medical costs 278.33 <0.0001 −306.79 0.0224 −313.60 <0.0001
Women+
Percentage of general or tertiary hospital utilization −0.0110 0.0005 −0.9660 <0.0001 0.0362 <0.0001
General or tertiary hospital utilization
Number of outpatient visits 0.0003 <0.0001 −0.0041 <0.0001 0.0001 0.8235
Outpatient medical costs 358.99 <0.0001 −1220.7 <0.0001 −536.60 <0.0001
Hospital or clinic utilization
Number of outpatient visits 0.0070 <0.0001 0.0311 <0.0001 −0.0096 <0.0001
Outpatient medical costs 352.36 <0.0001 −318.52 0.2383 −507.25 <0.0001
*Adjusted for age, sex, region, CCI, disability, and all cause admission at previous year
+Adjusted for age, income, region, CCI, disability, and all cause admission at previous year
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severe diseases. Accordingly, outpatients presenting for
52 mild diseases paying prescription drug costs differ-
ently depending on the hospital type represents a poten-
tial method of resolving the above matters.
The findings of the present study indicate that chan-
ging the coinsurance rate on prescription drug costs was
associated with changes in outpatient healthcare service
utilization. The introduction of the 2011 policy
decreased the number of outpatient visits in general or
tertiary hospitals. The number of outpatient visits in
hospitals or clinics increased with the introduction of
the 2011 policy; however, it decreased over time after
the 2011 policy. In addition, outpatient medical costs
decreased in both general or tertiary hospitals and hospi-
tals or clinics. Therefore, the 2011 policy, changing the
coinsurance rate on prescription drug costs, partially
shifted visits from general hospitals or tertiary hospitals
to clinics.
Studies have reported that cost sharing reduces the
needs of various health services and the burden of health
insurance [17]. The reducing rate of outpatient medical
cost increases for hospitals or clinics, despite the in-
crease in the number of outpatient visits immediately
after the 2011 policy, may be attributable to decreased
pharmaceutical use, which could be caused by reduced
unnecessary prescription drug treatment in the treat-
ment intensity, although the decision making process on
treatment intensity needs to be examined more carefully
[33]. However, the effect of cost sharing is likely to
involve side effects as our results demonstrate that the
number of outpatient visits for general or tertiary hospi-
tals tended to increase while that for hospitals or clinics
decreased over time after the 2011 policy [21]. There are
several possible explanations for these results. First, in-
creasing the coinsurance rate from 10 to 20% may have
been insufficient to prevent patients from excess visits to
general or tertiary hospitals, and the effect of the cost-
sharing policy may not have been maintained for a
substantial period of time [34]. Second, increased cost
sharing may be related to adverse events such as
hospitalization and worsening clinical outcomes due to
the decline in access to general or tertiary hospitals [33,
35]. Thus, the increase in hospitalization may have led
to a decrease in outpatients, causing the number of out-
patient visits for hospitals or clinics to decrease over
time. Additionally, the present study demonstrates that
both the number of outpatient visits and medical costs
associated with hypertension decreased compared to
other diseases after the 2011 policy in all medical care
organizations. This observation may be explained in two
ways. First, the policy increases the coinsurance rate for
patients with specific diagnostic codes. Thus, outpatients
with hypertension are able to continue visiting general
and tertiary hospitals using other diagnostic codes such
as for hypertensive heart disease (ICD-10: I11) rather
than essential hypertension (ICD-10: I10). Alternatively,
it is possible that hospitalization for hypertension in-
creased over the study period [21].
We examined the effect of the 2011 policy on health-
care utilization according to income and sex via
subgroup analysis. Income is an important factor for
cost-sharing policies. We observed that women were
more likely to be sensitive to the 2011 policy since the
absolute values of the coefficient for time after the im-
plementation of the 2011 policy were higher in women
than in men. This result was consistent with those of
previous studies [36, 37]. However, our study did not
identify any direct evidence for a difference in healthcare
utilization according to income level, despite previous
reports that patients with lower income are more sensi-
tive to the cost-sharing policy [18, 38, 39]. In the present
study, the increased coinsurance rate did not have a con-
sistent effect difference based on income. Thus, we were
unable to evaluate price elasticity or moral hazards.
As a result, the 2011 policy did not control healthcare
utilization and health insurance finance in the long term.
It is important to observe the effect of increasing the co-
insurance rate on prescription drug costs for 52 diseases
in the future. In addition, establishment of the criteria
for determining the primary diagnosis to prevent using
another diagnostic code and follow-up investigations for
continuously monitoring patients and hospitals are
needed.
The present study has some strengths compared to
previous studies. First, we used data from a nationally
representative large sample size, which reflect the overall
medical information of South Koreans. Such data are es-
pecially helpful in establishing evidence-based health
policies. Second, to our knowledge, there are few previ-
ous studies from South Korea that have analyzed the
correlations between policy introduction and healthcare
utilization with consideration of individual characteris-
tics. Although some studies have assessed policy effects,
they have used the total sum of outpatient visits and
medical costs per month rather than per person-month.
Thus, we are able to provide more detailed information
on the policy related to the coinsurance rate of prescrip-
tion drug costs.
The present study also had some limitations related to
limited data and methodology issues. First, there may
have been other external factors, not considered in our
study, which affected healthcare utilization. For example,
in the case of hypertension, the South Korean govern-
ment reformed the prices of existing drugs in April 2012
and revised guidelines restricting prescription for antihy-
pertensive drugs in January 2013. In addition, some indi-
viduals, irrespective of the coinsurance rate, prefer
general or tertiary hospitals over clinics. Thus, our
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results require careful interpretation. Further, since the
most frequently treated diseases of the 52 are influenced
by seasonal, socio-economic and demographic character-
istics, and personal health status, healthcare utilization
may have been affected [18, 40, 41]. Furthermore, de-
tailed covariates related with each disease were not ad-
justed as we analyzed all 52 diseases, which included
chronic diseases, as well as acute diseases. As each dis-
ease has different characteristics, other covariates may
be needed. Furthermore, we did not assess the severity
of disease as information related to this assessment was
not available in the present study. However, we consid-
ered severity (in terms of CCI) for a more detailed study.
Last, hospital characteristics, including the quality of the
offered services, were not captured in our study, and
there may be hospital effects such as quality on health-
care utilization.
Conclusions
Our findings demonstrate that the introduction of the
2011 policy increasing the coinsurance rate on prescrip-
tion drug costs decreased utilization of outpatient visits
in general or tertiary hospitals. However, outpatient
medical costs decreased in all medical care organiza-
tions. As we did not consider other external factors re-
lated to healthcare utilization in our analysis, it is not
clear whether decreased utilization of general or tertiary
hospitals transferred to demand for clinics or hospitals
care of the 2011 policy. This result indicates that the
price policy intended to change behaviors for healthcare
service utilization had limited effects on rebuilding the
healthcare system or the function of medical care
organizations.
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